Cancer Care Business Exchange

The Cancer Care Business Exchange is a high-level, multistakeholder forum that focuses on the business implications of the changing complexities in cancer care delivery and payment.

Cancer Care Business Breakthroughs

Breaking Down Health Care

The Bear: Why Does Health Care Cost So Much? (Part 1)

05/06/2024

Featuring Michael Kolodziej, MD, and John Hennessy, MBA

Featuring Michael Kolodziej, MD, and ...

In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...

In part one of this two-part...

05/06/2024

Cancer Care Business Exchange

Breaking Down Health Care

The Government and Health Care: A Volatile or Necessary Mix?

04/01/2024

Featuring Michael Kolodziej, MD, and John Hennessy, MBA

Featuring Michael Kolodziej, MD, and ...

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, cover the US federal government’s role in health care—Medicare, Medicaid, and the Affordable Care Act. They discuss the benefits, challenges, and...

In this Breaking Down Health...

04/01/2024

Cancer Care Business Exchange

Breaking Down Health Care

Why People Should Care About How Health Care Works

03/18/2024

Featuring Michael Kolodziej, MD, and John Hennessy, MBA

Featuring Michael Kolodziej, MD, and ...

In this first installment of the Breaking Down Health Care video series, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the fundamentals of how health care works in the United States, including covering the main payers, to set the...

In this first installment of the...

03/18/2024

Cancer Care Business Exchange

Videos

ONCare Alliance Merger Announcement: An Interview With Co-Founders Barbara McAneny, MD, and Sibel Blau, MD

03/11/2024

Featuring Barbara McAneny, MD, and Sibel Blau, MD

Featuring Barbara McAneny, MD, and Si...

Longtime industry leaders Barbara McAneny, MD, and Sibel Blau, MD, have joined forces to create ONCare Alliance, a strategic collaboration that aims to redefine the independent practice in community cancer care.

Longtime industry leaders...

03/11/2024

Cancer Care Business Exchange

News

ONCare Alliance Emerges as a Transformative Force in Independent Oncology and Cancer Care

02/29/2024

Brandon Twyford

Two leading oncology care organizations, the National Cancer Care Alliance (NCCA) and Quality Clinical Cancer Associates (QCCA), have joined forces to create ONCare Alliance, LLC.

Two leading oncology care...

02/29/2024

Cancer Care Business Exchange

Videos

AI in Health Care: Foundations, Myths, and Practical Applications

02/07/2024

Featuring Ira Klein, MD, MBA

Ira Klein, MD, MBA, vice president of medical affairs for Tempus Labs, provides insight into the future of AI in health care and how it will help cut down on mundane tasks and increase oncologists’ efficiency.

Ira Klein, MD, MBA, vice...

02/07/2024

Journal of Clinical Pathways

Videos

Insights from CPC+CBEx 2023

01/18/2024

Featuring John Hennessy, MBA

John Hennessy, MBA, details his highlights from CPC+CBEx 2023 and answers questions related to cancer care, industry consolidation, and the future of cancer care at home.

John Hennessy, MBA, details his...

01/18/2024

Journal of Clinical Pathways

Todd Schonherz, American Oncology Network

Videos

Healthcare Industry Consolidation And What This Means For Community Oncology Practices

11/21/2023

Featuring Todd Schonherz

Todd Schonherz, CEO of American Oncology Network, details his session on the impact that industry consolidation has had on community oncology practices at CPC+CBEx 2023.

Todd Schonherz, CEO of American...

11/21/2023

Journal of Clinical Pathways

Conference Coverage

CPC & CBEx Session Preview: Updates from Washington, Healthcare Industry Consolidation, and Cancer Care at Home

10/03/2023

Featuring Barbara McAneny, MD

CPC & CBEx faculty member Barbara McAneny, MD, gives a preview of her three featured sessions from the conference, including key points on health care industry consolidation, legislative updates, and important considerations for delivering...

CPC & CBEx faculty member...

10/03/2023

Journal of Clinical Pathways

Videos

Care Management Programs vs Value-Based Programs: The Path Forward

09/28/2023

Featuring Barry Russo, MBA; Brandy Manning, MSN, RN, OCN; Amy Valley, PharmD; and Tanya Park

Featuring Barry Russo, MBA; Brandy Ma...

In this Cancer Care Business Breakthroughs, Barry Russo, MBA, spoke with Brandy Manning, MSN, RN, OCN; Amy Valley, PharmD; and Tanya Park about why many oncology practices opted out of the Enhancing Oncology Model and what tools and resources...

In this Cancer Care Business...

09/28/2023

Cancer Care Business Exchange

Current Issue

April 2024

Volume 10

Issue 2

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

Biliary Tract Cancers (BTCs) Unveiled: Expert Perspectives on Unique Challenges and Management Considerations

11/20/2023

In this supplement, learn about the complexities of biliary tract cancer (BTC) with insights from a distinguished expert panel. The supplement examines the patient journey to diagnosis and treatment of BTCs, evaluates the impact of the...

In this supplement, learn about...

11/20/2023

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Cancer Care Business Exchange

Current Issue

Special Reports

Subscribe

Twitter

Specialties

Events

Year Round Education

HMP Global Products